SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001558370-19-002775
Filing Date
2019-04-03
Accepted
2019-04-03 16:18:07
Documents
5
Period of Report
2019-03-28
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 2.03: Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant
Item 3.02: Unregistered Sales of Equity Securities
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K f8-k.htm 8-K 43523
2 EX-10.1 ex-10d1.htm EX-10.1 300839
3 EX-10.2 ex-10d2.htm EX-10.2 232957
4 EX-10.3 ex-10d3.htm EX-10.3 215534
5 EX-10.4 ex-10d4.htm EX-10.4 225854
  Complete submission text file 0001558370-19-002775.txt   1020103
Mailing Address 1001 CALLE AMANECER SAN CLEMENTE CA 92673
Business Address 1001 CALLE AMANECER SAN CLEMENTE CA 92673 9494296680
ReShape Lifesciences Inc. (Filer) CIK: 0001371217 (see all company filings)

IRS No.: 481293684 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-33818 | Film No.: 19729214
SIC: 3845 Electromedical & Electrotherapeutic Apparatus